UK markets close in 3 hours 43 minutes

Akebia Therapeutics, Inc. (AKBA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.3231-0.0071 (-2.15%)
At close: 04:00PM EDT
0.3274 +0.00 (+1.33%)
Pre-market: 07:27AM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts4444
Avg. Estimate-0.31-0.19-0.97-0.44
Low estimate-0.36-0.25-1.16-0.7
High estimate-0.26-0.14-0.88-0.26
Year ago EPS-0.51-0.34-1.7-0.97
Revenue estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts3333
Avg. Estimate49.73M51.07M220.67M216.12M
Low estimate48M47M204.55M209.26M
High estimate51M56M229.45M228M
Year ago salesN/A49.67M213.58M220.67M
Sales growth (year/est)N/A2.80%3.30%-2.10%
Earnings history29/06/202129/09/202130/12/202130/03/2022
Est. EPS-0.32-0.32-0.33-0.29
Actual EPS-0.51-0.34-0.4-0.35
Difference-0.19-0.02-0.07-0.06
Surprise %-59.40%-6.30%-21.20%-20.70%
EPS trendCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Current estimate-0.31-0.19-0.97-0.44
7 days ago-0.25-0.18-0.82-0.44
30 days ago-0.23-0.2-0.81-0.65
60 days ago-0.21-0.21-0.91-0.64
90 days ago-0.22-0.18-0.81-0.49
EPS revisionsCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1212
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesAKBAIndustrySector(s)S&P 500
Current qtr.39.20%N/AN/AN/A
Next qtr.44.10%N/AN/AN/A
Current year42.90%N/AN/AN/A
Next year54.60%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A